First National Bank of South Miami’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-20
Closed -$2K 312
2020
Q4
$2K Hold
20
﹤0.01% 289
2020
Q3
$1K Sell
20
-175
-90% -$12.2K ﹤0.01% 265
2020
Q2
$13K Hold
195
0.01% 215
2020
Q1
$6K Buy
+195
New +$4.49K 0.01% 238

Other funds holding MRNA

First National Bank of South Miami's MRNA Position: Q1 2021 in Review

First National Bank of South Miami sold out of Moderna (MRNA) in Q1 2021, closing a stake of 20 shares — an estimated $2K sold.

First National Bank of South Miami first reported a position in MRNA in Q1 2020 and held it in 4 quarters. The position peaked at $13K in Q2 2020. 777 funds tracked by Wall St. Rank hold MRNA as of Q1 2021.

  • First National Bank of South Miami reported no remaining Moderna position as of Q1 2021 after selling out during the quarter.
  • First National Bank of South Miami sold 20 Moderna shares in Q1 2021, an estimated $2K.
  • First National Bank of South Miami first reported a position in Moderna in Q1 2020 and held it in 4 quarters.
  • First National Bank of South Miami's Moderna position peaked at $13K in Q2 2020.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q1 2021.

Based on First National Bank of South Miami's 13F filing for Q1 2021, filed 11 May 2021.